Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights [Yahoo! Finance]
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.